← Open Payments lookup

MELISSA WHITE: Open Payments

NPI 1033643432 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$756 in 40 payments from 9 companies in 2025. Trend: 2023 $208 · 2024 $420 · 2025 $756

Food & beverage: $756
CompanyPaymentsAmount
Gilead Sciences, Inc.18$380
ViiV Healthcare Company11$142
Merck Sharp & Dohme LLC4$96
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$40
Abbott Laboratories1$26
Takeda Pharmaceuticals U.S.A., Inc.1$25
AstraZeneca Pharmaceuticals LP1$19
Boehringer Ingelheim Pharmaceuticals, Inc.1$15
ABBVIE INC.1$14

Products named: PIFELTRO, DOVATO, Biktarvy, APRETUDE, XIFAXAN, PROCLAIM, TRINTELLIX, FARXIGA.

Industry payments across MS — which companies pay providers there.